Garg Pushkal - Insider Transactions
Insider Type
individual
Companies
1
Average
245,295
Total Txns
108
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2024 | 0 | 32 | -32 | 0.00 | 1,630,488.16 | -1,630,488.16 |
| 2025 | 0 | 76 | -76 | 0.00 | 24,861,319.47 | -24,861,319.47 |
| Total: | 0 | 108 | 10 | 0.00 | 26,491,807.63 | -26,491,807.63 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
450.81 USD |
541 Sold |
243,888 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
449.79 USD |
249 Sold |
111,998 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
453.77 USD |
329 Sold |
149,290 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
451.86 USD |
332 Sold |
150,018 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
447.92 USD |
56 Sold |
25,084 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
452.69 USD |
668 Sold |
302,397 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
454.84 USD |
244 Sold |
110,981 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
453.77 USD |
329 Sold |
149,290 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
448.77 USD |
180 Sold |
80,779 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
446.53 USD |
115 Sold |
51,351 USD |
01/10/2025 | 02/10/2025 |